Authors/Disclosures
|
Amy S. Chappell, MD, FAAN
|
Dr. Chappell has received personal compensation for serving as an employee of Eliem Therapeutics. Dr. Chappell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pinteon. Dr. Chappell has received stock or an ownership interest from Eliem. |
|
Jerry A. Hall
|
No disclosure on file |
|
Vladimir Skljarevski, MD
(Eli Lilly and Company)
|
No disclosure on file |
|
Rashedul Hasan, MD
(Baylor Regional Medical Center Plano)
|
No disclosure on file |
|
Soojin Park, MD
|
Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health. |